Diabetes and COVID-19 risk: an miRNA perspective

Coronavirus disease 2019 (COVID-19) and diabetes outcomes (CORONADO) trial revealed that 10.6% of patients with diabetes mellitus hospitalized for COVID-19 (COVID-19) die within 7 days. Several studies from New York, Italy, and China confirm that patients with diabetes are at a much higher risk for mortality due to COVID-19. Besides respiratory illness, COVID-19 increases cardiac injury and diabetic ketoacidosis. In the absence of specific guidelines for the prevention and treatment of COVID-19 for patients with diabetes, they remain at higher risk and are more susceptible to COVID-19.

Source: Diabetes and COVID-19 risk: an miRNA perspective | American Journal of Physiology-Heart and Circulatory Physiology

Interesting read….just another tidbit to understand about life and its pitfalls! Since I am diabetic, this hits home for me…



kKEETON @ Windows to Russia…

Permission to reprint in whole or in part is gladly granted, provided full credit is given...

Leave a Reply

Your email address will not be published. Required fields are marked *